RE:RE:RE:probably time to start adding to my positionAgreed re: accomplishments to date. Little to no risk on the product.
Also the momentum seems to be resuming to the pre covid turmoil.
I like the track record of Mr. Malek when I look at BVT's managment.
In researching them prior to investing in 2019 what caught my attention was Ashish Malek's involvement as a V.P. with Bayer Crop Science and that he had worked prior
with AgraQuest a Davis biotech company bought by Bayer back in 2012 for a tidy
$412 million U.S. AgraQuest revenue had been only $40 million in 2011
The links below are the sources to the above info
https://www.croplife.com/crop-inputs/bayer-cropscience-completes-agraquest-acquisition/#:~:text=%E2%80%9CThe%20combined%20talents%20and%20capabilities,a%20purchase%20price%20of%20US%24
https://www.marketwatch.com/story/bayer-buys-agraquest-adds-to-biopesticide-lines-2012-07-04
https://www.sacbee.com/news/business/article98792357.html